Isoquercitrin Attenuates Steatohepatitis by Inhibition of the Activated NLRP3 Inflammasome through HSP90
International Journal of Molecular Sciences · 15.05.2023 · 24 (10) · 8795
DOI: 10.3390/ijms24108795 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 15.05.2023. Verfasst von Ji Ma und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China. Hauptthemen laut MEDLINE: Inflammasomes, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Technology Major Project of China.
Abstract (Originalsprache)
Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease with a global prevalence of 25%. However, the medicines approved by the FDA or EMA are still not commercially available for the treatment of NAFLD. The NOD-like receptor thermal protein domain-associated protein 3 (NLRP3) inflammasome plays a crucial role in inflammatory responses, and the mechanisms related to steatohepatitis have been sufficiently clarified. NLRP3 has been widely evaluated as a potential target for multiple active agents in treating NAFLD. As a quercetin glycoside, isoquercitrin (IQ) has a broad inhibitory effect on oxidative stress, cancers, cardiovascular diseases, diabetes, and allergic reactions in vitro and in vivo. This study aimed to investigate the undercover mechanism of IQ in the treatment of NAFLD, particularly in anti-steatohepatitis, by suppressing the NLRP3 inflammasome. In this study, a methionine-choline-deficient induced steatohepatitis mice model was used to explore the effect of IQ on NAFLD treatment. Further mechanism exploration based on transcriptomics and molecular biology revealed that IQ inhibited the activated NLRP3 inflammasome by down-regulating the expression of heat shock protein 90 (HSP90) and suppressor of G-two allele of Skp1 (SGT1). In conclusion, IQ could alleviate NAFLD by inhibiting the activated NLRP3 inflammasome by suppressing the expression of HSP90.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China.
- Jiangsu Key Laboratory of TCM Evaluation and Translational Research, China Pharmaceutical University, Nanjing 211198, China.
ORCID-Profile: Ji Ma
Förderung
- National Science Technology Major Project of China
Zitieren
APA
Ma, J., Li, M., Yang, T., Deng, Y., Ding, Y., Guo, T., & Shang, J. (2023). Isoquercitrin Attenuates Steatohepatitis by Inhibition of the Activated NLRP3 Inflammasome through HSP90. International Journal of Molecular Sciences, 24(10), 8795. https://doi.org/10.3390/ijms24108795
Vancouver
Ma J, Li M, Yang T, Deng Y, Ding Y, Guo T, et al. Isoquercitrin Attenuates Steatohepatitis by Inhibition of the Activated NLRP3 Inflammasome through HSP90. International Journal of Molecular Sciences. 2023;24(10):8795. doi:10.3390/ijms24108795
BibTeX
@article{Ma2023,
author = {Ma, Ji and Li, Maoru and Yang, Tingting and Deng, Yang and Ding, Yadong and Guo, Tiantian and Shang, Jing},
title = {Isoquercitrin Attenuates Steatohepatitis by Inhibition of the Activated NLRP3 Inflammasome through HSP90},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {10},
pages = {8795},
doi = {10.3390/ijms24108795}
}
EUVIMED